Publications

Search our bibliography using the filters on the right-hand side.

Displaying 201 through 250 of 371 publications.

Warren DK, Nickel KB, Wallace AE, Mines D, Frazer VJ, Olsen MA. Validation of claims data to identify surgical site infections with antibiotic utilization data. Poster presented at the 30th ICPE International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 2014. Taipei, Taiwan. [abstract] Pharmacoepidemiol Drug Saf. 2014 Sep 30; 23(S1).

Hoffman V, Xue F, Gardstein B, Skerry K, Critchlow CW, Enger C. Development and evaluation of an algorithm to identify users of Prolia during the early postmarketing period using health insurance claims data. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):993-8. doi: 10.1002/pds.3680

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014 May;23(5):548-53. doi: 10.1002/pds.3575

Edwards T, Cadigan RJ, Evans JP, Henderson GE. Biobanks containing clinical specimens: defining characteristics, policies, and practices. Clin Biochem. 2014 Mar;47(4-5):245-51. doi: 10.1016/j.clinbiochem.2013.11.023

Pisa F, Castellsague J, Drigo D, Riera Guardia N, Giangreco M, Rosolen V, Clagnan E, Zanier L, Perez-Gutthann S, Barbone F. Accuracy of ICD-9-CM codes for upper gastrointestinal complications vaired by position and age: a validation study in a cohort of NSAID users in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf. 2013 Nov 22;22(11):1195-204. doi: 10.1002/pds.3504

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Margulis A, Pladevall M, Miguel G, Romio S, Sturkenboom M, Perez-Gutthann S. Cardiovascular risk with glitazones and metformin: results from a systematic review of observational studies. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2013. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct 7; 22(S1):68.

Riera Guardia N, Margulis AV, Pladevall-Vila M, Varas-Lorenzo C, Perez-Gutthann S. Methods issues in observational studies of the cardiovascular risk associated with glucose-lowering medications: results of a systematic review and evaluation. Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; October 7, 2013. [abstract] Pharmacoepidemiol Drug Saf. 22(Suppl 1):S80-81.

Wahl PW, Rassen JA, Rosenman MB, Mines D, Glynn RJ, Schneeweiss S. Information gained by linking administrative claims to structured electronic health record data in a statin comparative effectiveness study. Presented at the 2013 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):30. doi: 10.1002/pds.3512

Toh S, Avorn J, D'Agostino RB, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MCJM, Vandenbroucke JP, Winterstein AG, Strom BL. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1036-45.

Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-utility analysis of various chemotherapy regimens among elderly ovarian cancer patients: a longitudinal cohort study. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Conference; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):172. doi: 10.1002/pds.3512

Layton JB, Brookhart MA, Jonsson Funk M, Simpson, Jr RJ, Pate V, Sturmer T, Kshirsagar AV. Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1061-70. doi: 10.1002/pds.3500

Esposito DB, Lensen L, Eisenberg DF, Grant A, Hawes JCL, Holick CN, Ke X, Luthra R, Maloney J, Mehta V, Mines D. Background rates of anaphylaxis in general and allergic populations. Poster presented at the 2013 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Quebec. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):397.

Pisa F, Castellsague J, Drigo D, Riera-Guardia N, Giangreco M, Rosolen V, Clagnan E, Zanier L, Perez-Gutthann S, Barbone F. Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf. 2013 Aug 20;22(11):1195-204.

Tennis PS, Johannes CB, Camargo C, Sturmer T, Lanes S, Brown J, Andrews EB, Davis K, Schatz M. Feasibility of ruling out small treatment-associated increase in asthma mortality risk. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):S34-5. doi: 10.1002/pds.3512

Everage NJ, Esposito DB, Li Z, Deshpande G, Holick CN, Chan KA, Mines D. Positive predictive values of algorithms for ascertainment of major congenital malformations in administrative databases. Presented at the 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):194.

Midkiff K, Johannes C, Tennis P, Calingaert B, McQuay L, Harris DH, Andrews E. Identifying causes of death in a large cohort of asthma patients. Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):300.

Johannes C, McQuay L, Tennis P, Camargo CA, Schatz M, Midkiff K, Lanes S, DiSantostefano R, Davis K. Characteristics of initiators of asthma maintenance medications in 10 health care populations. Poster presented at the 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):273-4.

Gilsenan AW, Harris DH, Midkiff KD, Andrews EB, Kellier N, Masica D. Approaches to long-term surveillance for rare cancer events. Poster presented at the 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Aug; 22(Suppl 1):218-9.

Varas-Lorenzo C, Riera Guardia N, Castellsague J, Arfe A, Perez-Gutthann S. The SOS project: risk of heart failure and use of nonsteroidal anti-inflammatory drugs. A meta-analysis of observational studies. Poster presented at the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. [abstract] Pharmacoepidemiol Drug Saf. 22(S1):67.

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):559-70.

Castellsague J, Pisa F, Rosolen V, Drigo D, Riera Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf. 2013 Apr 22;22(4):365-75.

Brunelli SM, Gagne JJ, Huybrechts KF, Wang SV, Patrick AR, Rothman KJ, Seeger JD. Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates. Pharmacoepidemiol Drug Saf. 2013 Mar 22;Advance Online.

Kilpatrick RD, Gilbertson D, Brookhart MA, Polley E, Rothman KJ, Bradbury BD. Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions. Pharmacoepidemiol Drug Saf. 2013 Feb 1;22(2):111-21.

Thyagarajan (Hoffman) V, Robin Clifford C, Wurst KE, Ephross SA, Seeger JD. Bupropion therapy in pregnancy and the occurrence of cardiovascular malformations in infants. Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1240-2. doi: 10.1002/pds.3271

Midkiff K, Calingaert B, Tennis P, Harris DH, Andrews EB. Using an automated computer-based algorithm to increase the efficiency of selecting the best match from national death index linkage results. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona. [abstract] Pharmacoepidemiol Drug Saf. 2012 Sep 5; 21(Suppl 3):S396.

Kaye JA, Castellsague J, Bui C, Calingaert B, McQuay LJ, Riera N, Saltus C, Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ, Wallander MA, Perez-Gutthann S. Risk of acute liver injury in a cohort of oral antimicrobial users. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Supp 3):92. doi: 10.1002/phar.1367

Riera-Guardia N, Saltus C, Bui C, Harris DH, Kaye JA, Tennis P, Castellsague J, Perez-Gutthann S. Back in Barcelona: the landscape of database research over the last decade. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2012. Barcelona. [abstract] Pharmacoepidemiol Drug Saf. 21(Suppl 3):S306-7.

Gilsenan AW, Kellier N, Harris DH, Andrews EB, Masica DN. Linking a voluntary patient registry with US state cancer registries for possible signal detection. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 23, 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(suppl 3):464. doi: 10.1002/pds.3324

Afonso A, Prieto-Alhambra D, Escudero Garcia A, Estany Gestal A, Martin-Merino E, Riera Guardia N, Lopez-Leon S, Perez-Gutthann S, Hernández-Díaz S. FarmacoEpiEnRed, a network for pharmacoepidemiology in Spain. Poster presented at the 28th International Conference on Pharmacoepidemiology; August 27, 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Suppl 3):193. doi: 10.1002/pds.3324

Mines D, Tennis PS, Curkendall S, Li A, Peterson C, Andrews EB, Calingaert B, Rothman KJ. Topiramate use in pregnancy and risk of oral clefts. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):320. doi: 10.1111/j.1399-5448.2012.03324.x

Tennis P, Rothman KJ, Bohn RL, Tan H, Zavras A, Laskarides C, Calingaert B, Anthony MS. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf. 2012 Aug 1;21(8):810-7.

Yong M, Schenfeld J, Anthony M, Pariser D, Kimball AB. Malignancy and infection rates in psoriasis patients with or without treatment and in a general population in the US: 2005 – 2009. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21((Suppl 3)):42.

Salvo F, Fourrier-Reglat A, Bazin F, Nicotra F, Riera Guardia N, Hagg M. The SOS project: incidences of reported cardiovascular events in RCT. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):416-7.

Pisa F, Castellsague J, Rosolen V, Riera-Guardia N, Giangreco M, Drigo D, Perez-Gutthann S. Impact of case validation on incidence rates of upper gastrointestinal complications. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):178. doi: 10.1002/pds.3324

Lunt M, Wyss R, Glynn R, Poole C, Rothman KJ. An example in which omitting an instrumental variable from a propensity score leads to a biased estimate of the effect of an exposure. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Supp 3):125-6.

Blackburn SCF, Arlett PR, Evans SJ, Perez-Gutthann S. New pharmacovigilance legislation: a call to arms to the pharmacoepidemiology community. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):339.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Risk factors for incident diabetic retinopathy in type II diabetes in UK primary care. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S3.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Validation of diabetic retinopathy and maculopathy diagnoses recorded in a United Kingdom primary care database. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S164-5.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Incidence of diabetic maculopathy among patients with diabetic retinopathy. Poster presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S272.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Risk factors for incident diabetic macular edema in type II diabetes in UK primary care. Poster presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S272-3.

Tse (Kawai) A, Tseng HF, Greene SK, Vellozzi C, Weintraub E, McCarthy N. Risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):365-6.

Gastanaga VM, Bui C, Gutierrez L, Taylor A, Kelsh MA. Epidemiology of metastatic pancreatic cancer in the United States and selected European countries. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Supp 3):S469-70.

Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses. Pharmacoepidemiol Drug Saf. 2012 Jul 1;21(7):697-709.

Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Response to commentary by Marcus and Gibbons. Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):713.

Rowan CG, Brunelli SM, Munson J, Flory J, Reese PP, Hennessy S, Lewis J, Mines D, Barrett JS, Bilker W, Strom BL. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2012 May;21(5):494-506. doi: 10.1002/pds.3199

Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012 May 1;21(Suppl. 2):69-80.

Nkohma E, Zhao Y, Esposito D, Mines D, Holick C. Patterns of medication use during pregnancy and prevalence of birth defects in a large administrative claims database. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):390.

Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. Optimal approaches to one-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(Supp 3):S34-5.

Sturkenboom M, Fourrier-Reglat A, Perez-Gutthann S, Garbe E, Nicotra F, Romio S. How to conduct collaborative studies in the EU? Lessons and results from the completed Safety of NSAIDs (SOS) Project. Pharmacoepidemiol Drug Saf. 2012;21(suppl 3):S38-9.

Vandenberghe F, Choong E, Saigi-Morgui N, Quteineh L, Ambresin AE, von Gunten A, Conus P, Eap CB. Clinical study on psychotropic drug induced weight gain and other metabolic complications in a Swiss psychiatric population. Poster presented at the 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):456. doi: 10.1002